• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Relation of haemostatic, fibrinolytic, and rheological variables to the angiographic extent of peripheral arterial occlusive disease.

作者信息

Woodburn K R, Lowe G D, Rumley A, Love J, Pollock J G

机构信息

University Department of Medicine, Glasgow Royal Infirmary, UK.

出版信息

Int Angiol. 1995 Sep;14(3):219-25.

PMID:8919237
Abstract

We investigated the relationships between the angiographic severity of peripheral arterial occlusive disease (PAOD) and haemostasis, fibrinolytic, and rheological variables in 219 patients with symptomatic peripheral arterial occlusive disease (PAOD). White cell count, fibrinogen, cross-linked fibrin degradation products (FDP), von Willebrand factor, and plasminogen activator inhibitor levels were all elevated in comparison with age-matched population controls (all p < 0.0001, Mann-Whitney U test), while fibrinogen (Spearman r = 0.30), von Willebrand factor (r = 0.40), and log (FDP) (r = 0.56), (all p < 0.0001) showed a strong correlation with the angiographic extent of PAOD. Multivariate analysis indicated that log (FDP) was a strong independent predictor of the angiographic severity of PAOD (p < 0.0001), in addition to increasing age (p < 0.0001), presence of tissue sepsis (p < 0.02), prior vascular surgery (p = 0.007), and other vascular pathology (p = 0.007). These results confirm that increases in fibrinogen, von Willebrand factor, plasminogen activator inhibitor and fibrin turnover, are strongly associated with the presence of symptomatic peripheral arterial disease, and suggest that there may be causal link between fibrin turnover, as determined by FDP levels, and the extent of peripheral arterial occlusive disease.

摘要

相似文献

1
Relation of haemostatic, fibrinolytic, and rheological variables to the angiographic extent of peripheral arterial occlusive disease.
Int Angiol. 1995 Sep;14(3):219-25.
2
Relation of haemostatic, fibrinolytic, and rheological variables to the angiographic extent of peripheral arterial occlusive disease.
Int Angiol. 1995 Dec;14(4):346-52.
3
Fibrinogen and markers of fibrinolysis and endothelial damage following resolution of critical limb ischaemia.严重肢体缺血缓解后的纤维蛋白原、纤溶及内皮损伤标志物
Eur J Vasc Endovasc Surg. 1995 Oct;10(3):272-8. doi: 10.1016/s1078-5884(05)80042-5.
4
Alteration of the fibrinolytic system in patients with peripheral arterial occlusive disease.外周动脉闭塞性疾病患者纤溶系统的改变。
Vasa. 1999 May;28(2):106-11. doi: 10.1024/0301-1526.28.2.106.
5
Haemostatic and rheological factors in intermittent claudication: the influence of smoking and extent of arterial disease.间歇性跛行中的止血和流变学因素:吸烟及动脉疾病程度的影响
Br J Haematol. 1996 Jan;92(1):226-30. doi: 10.1046/j.1365-2141.1996.00283.x.
6
Haemostatic derangement in advanced peripheral occlusive arterial disease.
Int Angiol. 1999 Dec;18(4):256-62.
7
Post-thrombolysis haemostasis changes after rt-PA treatment in acute cerebral infarct. Correlations with cardioembolic aetiology and outcome.急性脑梗死患者rt-PA治疗后溶栓后止血变化。与心源性栓塞病因及预后的相关性。
J Neurol Sci. 2015 Feb 15;349(1-2):77-83. doi: 10.1016/j.jns.2014.12.029. Epub 2014 Dec 29.
8
Role of hemostatic risk factors for restenosis in peripheral arterial occlusive disease after transluminal angioplasty.经皮腔内血管成形术后外周动脉闭塞性疾病再狭窄的止血危险因素作用。
Arterioscler Thromb Vasc Biol. 1997 Nov;17(11):3208-14. doi: 10.1161/01.atv.17.11.3208.
9
Hemostasis and fibrinolysis in patients with intermittent claudication: effects of prostaglandin E1.间歇性跛行患者的止血与纤溶:前列腺素E1的作用
Prostaglandins Leukot Essent Fatty Acids. 2000 Nov;63(5):271-7. doi: 10.1054/plef.2000.0214.
10
Fibrin D-dimer, haemostatic factors and peripheral arterial disease.纤维蛋白D - 二聚体、止血因子与外周动脉疾病
Thromb Haemost. 1995 Sep;74(3):828-32.